Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03729245
Brief Title: A Study of NKTR-214 in Combination With Nivolumab Compared With the Investigator's Choice of a Tyrosine Kinase Inhibitor (TKI) Therapy (Either Sunitinib or Cabozantinib Monotherapy) for Advanced Metastatic Renal Cell Carcinoma (RCC)

First Submitted : October 29, 2018
First Submitted that Met QC Criteria : October 31, 2018
First Posted : November 2, 2018

Last Update Submitted that Met QC Criteria : October 15, 2019
Last Update Posted : October 17, 2019 (Estimate)